Biomarker discovery solution
Biomarkers are indicators of disease occurrence and progression. Biomarkers can be used to measure and evaluate normal biological and pathogenic processes, or pharmacologic responses to a therapeutic intervention, and in some cases they may serve as potential drug targets.
We provide multi-omics solutions to discover biomarkers, aiming to help researchers to accelerate the process of drug discovery and development. By combining our multiple technologies (Next-generation sequencing, Sanger sequencing, Genotyping, Mass spectrometry), we can study variants from genomic to trancriptomic and proteomic levels. These multi-omics solutions enhance the strength of combinational analysis to discover disease related biomarkers for further validation.
Simply providing case and control samples and discussing your needs with us, our scientists will suggest a suitable strategy for your biomarker discovery and perform high quality service to facilitate your research.
The following graph provides an overview of multi-omics approaches that can be applied in biomarker discovery.
To learn more, please download the Biomarker Discovery Solution brochure.